43808 Federal Register / Vol. 82, No. 180 / Tuesday, September 19, 2017 / Notices 

Willis Tower 233 S. Wacker Drive, 

Metropolitan Club, 66th Floor, Oak 

Room, Chicago, Illinois 60606. 

FOR FURTHER INFORMATION CONTACT: 

Andy Cebula, NAC Secretariat, (202) 

330–0652, acebula@rtca.org, 1150 18 

Street NW., Suite 910, Washington, DC 

20036, or by fax at (202) 833–9434, or 

Web site at http://www.rtca.org. 

SUPPLEMENTARY INFORMATION: Pursuant 

to section 10(a)(2) of the Federal 

Advisory Committee Act (Pub. L. 92– 

463, 5 U.S.C., App.), notice is hereby 

given for a meeting of the Twenty 

Second Meeting of the NextGen 

Advisory Committee (NAC). The agenda 

will include the following: 

October 4, 2017 9:00 a.m.–2:00 p.m. 

1. Opening of Meeting/Introduction of 

NAC Members—Chairman David 

Bronczek 

2. Official Statement of Designated 

Federal Officer—Dan Elwell, FAA 

Deputy Administrator 

3. Review and Approval of June 28, 

2017 Meeting Summary and 

Revised Terms of Reference 

4. Chairman’s Report—Chairman 

Bronczek 

5. FAA Report—FAA 

6. Making Single European Sky ATM 

Research (SESAR) a Performing 

Operational Reality 

7. Northeast Corridor Phase Two 

Tasking—Interim Report; Action 

Item: Consideration for Approval 

8. Joint Analysis Team—Boston 

Optimized Profile Descent/ 

DataComm Benefits Assessment— 

Final Report; Action Item: 

Consideration for Approval 

9. Regional Airline Equipage 

10. NextGen Priorities Status—NextGen 

Integration Working Group (NIWG): 

Performance Based Navigation 

(PBN), Data Communications, 

Surface Operations & Data Sharing, 

Multiple Runway Operations; 

Action Item: Consideration for 

Approval of 2017 NextGen 

Priorities Joint Implementation Plan 

11. Equipage Status 

12. Other business 

13. Summary of Meeting and next steps 

14. Closing Comments—DFO and NAC 

Chairman 

15. Adjourn 

Although the NAC meeting is open to 

the public, the meeting location has 

limited space and security protocols 

that require advanced registration. To 

attend: Please email bteel@rtca.org with 

name, company, and phone number 

contact to pre-register no later than 

September 25, 2017. 

With the approval of the chairman, 

members of the public may present oral 

statements at the meeting. Persons 

wishing to present statements or obtain 

information should contact the person 

listed in the FOR FURTHER INFORMATION

CONTACT section. Members of the public 

may present a written statement to the 

committee at any time. 

Issued in Washington, DC, on September 

14, 2017. 

Mohannad Dawoud, 

Management & Program Analyst, Partnership 

Contracts Branch, ANG–A17, NextGen, 

Procurement Services Division. 

[FR Doc. 2017–19892 Filed 9–14–17; 4:15 pm] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[FMCSA Docket No. FMCSA–2017–0037] 

Qualification of Drivers; Exemption 

Applications; Diabetes Mellitus 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to exempt 29 individuals from 

the prohibition in the Federal Motor 

Carrier Safety Regulations (FMCSRs) 

against persons with insulin-treated 

diabetes mellitus (ITDM) from operating 

a commercial motor vehicle (CMV) in 

interstate commerce. The exemptions 

enable these individuals with ITDM to 

operate CMVs in interstate commerce. 

DATES: The exemptions were applicable 

on July 7, 2017. The exemptions expire 

on July 7, 2019. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE., Room W64– 

224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., E.T., Monday through Friday, 

except Federal holidays. If you have 

questions regarding viewing or 

submitting material to the docket, 

contact Docket Services, telephone (202) 

366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Electronic Access 

You may see all the comments online 

through the Federal Document 

Management System (FDMS) at: http:// 

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or 

comments, go to http://

www.regulations.gov and/or Room 

W12–140 on the ground level of the 

West Building, 1200 New Jersey Avenue 

SE., Washington, DC, between 9 a.m. 

and 5 p.m., E.T., Monday through 

Friday, except Federal holidays. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to http://www.regulations.gov, 

as described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at http://www.dot.gov/ 

privacy. 

II. Background 

On June 6, 2017, FMCSA published a 

notice announcing receipt of 

applications from 29 individuals 

requesting an exemption from diabetes 

requirement in 49 CFR 391.41(b)(3) and 

requested comments from the public (82 

FR 26226). The public comment period 

ended on July 6, 2017, and no 

comments were received. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

granting the exemptions to these 

individuals would achieve a level of 

safety equivalent to or greater than the 

level that would be achieved by 

complying with the current regulation 

49 CFR 391.41(b)(3). 

The physical qualification standard 

for drivers regarding diabetes found in 

49 CFR 391.41(b)(3) states that a person 

is physically qualified to drive a CMV 

if that person: 

Has no established medical history or 

clinical diagnosis of diabetes mellitus 

currently requiring insulin for control. 

III. Discussion of Comments 

FMCSA received no comments in this 

proceeding. 

IV. Basis for Exemption Determination 

Under 49 U.S.C. 31136(e) and 31315, 

FMCSA may grant an exemption from 

the diabetes standard in 49 CFR 

391.41(b)(3) if the exemption is likely to 

achieve an equivalent or greater level of 

safety than would be achieved without 

the exemption. The exemption allows 

the applicants to operate CMVs in 

interstate commerce. 

The Agency’s decision regarding these 

exemption applications is based on the 

program eligibility criteria and an 

individualized assessment of 

information submitted by each 

applicant. 

These 29 applicants have had ITDM 

over a range of 1 to 37 years. These 

applicants report no severe 

hypoglycemic reactions resulting in loss 

of consciousness or seizure, requiring 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 180 / Tuesday, September 19, 2017 / Notices 43809 

the assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning 

symptoms, in the past 12 months and no 

recurrent (two or more) severe 

hypoglycemic episodes in the past five 

years. In each case, an endocrinologist 

verified that the driver has 

demonstrated a willingness to properly 

monitor and manage his/her diabetes 

mellitus, received education related to 

diabetes management, and is on a stable 

insulin regimen. These drivers report no 

other disqualifying conditions, 

including diabetes related 

complications. Each meets the vision 

requirement at 49 CFR 391.41(b)(10). 

The qualifications, experience, and 

medical condition of each applicant 

were stated and discussed in detail in 

the June 6, 2017, Federal Register notice 

(82 FR 26226) and will not be repeated 

in this notice. 

Consequently, FMCSA finds that in 

each case exempting these applicants 

from the diabetes requirement in 49 CFR 

391.41(b)(3) is likely to achieve a level 

of safety equal to that existing without 

the exemption. 

V. Conditions and Requirements 

The terms and conditions of the 

exemption are provided to the 

applicants in the exemption document 

and includes the following: (1) Each 

driver must submit a quarterly 

monitoring checklist completed by the 

treating endocrinologist as well as an 

annual checklist with a comprehensive 

medical evaluation; (2) each driver must 

report within two business days of 

occurrence, all episodes of severe 

hypoglycemia, significant 

complications, or inability to manage 

diabetes; also, any involvement in an 

accident or any other adverse event in 

a CMV or personal vehicle, whether or 

not it is related to an episode of 

hypoglycemia; (3) each driver must 

provide a copy of the ophthalmologist’s 

or optometrist’s report to the Medical 

Examiner at the time of the annual 

medical examination; and (4) each 

driver must provide a copy of the 

annual medical certification to the 

employer for retention in the driver’s 

qualification file, or keeping a copy in 

his/her driver’s qualification file if he/ 

she is self-employed. The driver must 

also have a copy of the exemption when 

driving, for presentation to a duly 

authorized Federal, State, or local 

enforcement official. 

VI. Preemption 

During the period the exemption is in 

effect, no State shall enforce any law or 

regulation that conflicts with this 

exemption with respect to a person 

operating under the exemption. 

VII. Conclusion 

Based upon its evaluation of the 29 

exemption applications, FMCSA 

exempts the following drivers from the 

diabetes requirement in 49 CFR 

391.41(b)(10), subject to the 

requirements cited above: 

Tyler J. Bren (ND) 

Charlie H. Brown, Jr. (GA) 

Ajax A. Castro (FL) 

Robert J. Conklin (PA) 

Luke S. Davidson (CA) 

Joseph R. DePra (IN) 

Joseph P. Finan (RI) 

Luis Garcia (NJ) 

Eric E.T. Gheen (OH) 

Aron A. Hanson (IL) 

Tyler J. Hanson (ID) 

Antonio K. Hoes (MD) 

Ronald O. Knighten (WA) 

Stephen P. Koons (PA) 

Angel Luna (PA) 

David Mills (NH) 

Kenneth J. Moe (MN) 

James L. Pearson (NY) 

Walter R. Rentsch (SD) 

Richard D. Revere (PA) 

Redmond L. Riley (NC) 

James H. Roth, Jr. (PA) 

Stephen R. Shaffer (KS) 

Matthew J. Thornton (OR) 

Michael H. Trayah (VT) 

William Wagstaff, 3rd (MD) 

Craig A. Wildenberg (WI) 

Ronald E. Wulf (MN) 

Samuel K. Zeweldie (GA) 

In accordance with 49 U.S.C. 31136(e) 

and 31315, each exemption will be valid 

for two years from the effective date 

unless revoked earlier by FMCSA. The 

exemption will be revoked if the 

following occurs: (1) The person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained prior to being granted; 

or (3) continuation of the exemption 

would not be consistent with the goals 

and objectives of 49 U.S.C. 31136(e) and 

31315. 

Issued on: September 13, 2017. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2017–19907 Filed 9–18–17; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2006–26367] 

Medical Review Board (MRB) Meeting: 

Public Meeting 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Announcement of advisory 

committee public meeting. 

SUMMARY: FMCSA announces a meeting 

of its Medical Review Board (MRB) on 

Tuesday and Wednesday, September 

26–27, 2017. The MRB will make 

recommendations to the Agency on the 

revision of the Agency’s handbook for 

medical examiners (ME) who are on the 

National Registry of Certified Medical 

Examiners (National Registry), for their 

use in evaluating interstate commercial 

motor vehicle (CMV) drivers for a 

medical qualification determination. 

Additionally, the MRB will review the 

Agency’s current advisory and 

exemption program criteria concerning 

individuals taking anti-seizure 

medication and identify factors the 

Agency should consider for potential 

regulatory actions that would eliminate 

the need for granting exemptions. The 

meeting is open to the public for its 

entirety. The public will be allowed to 

comment during the proceedings. 

DATES: The meeting will be held on 

Tuesday and Wednesday, September 

26–27, 2017, from 9:15 a.m. to 4:30 

p.m., Eastern Daylight Time (E.T.), at 

the FMCSA National Training Center, 

1310 N. Courthouse Road, Arlington, 

VA, 6th Floor. Copies of the task 

statement and an agenda for the entire 

meeting will be made available in 

advance of the meeting at 

www.fmcsa.dot.gov/mrb. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Shannon L. Watson, Senior Advisor to 

the Associate Administrator for Policy, 

Federal Motor Carrier Safety 

Administration, U.S. Department of 

Transportation, 1200 New Jersey 

Avenue SE., Washington, DC 20590, 

(202) 366–5221, mrb@dot.gov. 

Services for Individuals With 

Disabilities 

For information on facilities or 

services for individuals with disabilities 

or to request special assistance at the 

meeting, contact Eran Segev at (617) 

494–3174, eran.segev@dot.gov, by 

Wednesday, September 20. 

SUPPLEMENTARY INFORMATION: 


asabaliauskas on DSKBBXCHB2PROD with NOTICES